avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Spi1 | mm10_v2_chr2_+_91082362_91082390 | 0.83 | 2.9e-10 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_87793722 Show fit | 26.67 |
ENSMUST00000143021.2
|
myeloperoxidase |
|
chr3_+_103832562 Show fit | 22.10 |
ENSMUST00000062945.5
|
BCLl2-like 15 |
|
chr11_+_87793470 Show fit | 21.52 |
ENSMUST00000020779.4
|
myeloperoxidase |
|
chr7_-_127137807 Show fit | 20.18 |
ENSMUST00000049931.5
|
sialophorin |
|
chrX_-_7964166 Show fit | 20.14 |
ENSMUST00000128449.1
|
GATA binding protein 1 |
|
chr3_-_90695706 Show fit | 20.11 |
ENSMUST00000069960.5
ENSMUST00000117167.1 |
S100 calcium binding protein A9 (calgranulin B) |
|
chr7_-_142661858 Show fit | 19.78 |
ENSMUST00000145896.2
|
insulin-like growth factor 2 |
|
chr8_+_72761868 Show fit | 16.33 |
ENSMUST00000058099.8
|
coagulation factor II (thrombin) receptor-like 3 |
|
chr2_+_84980458 Show fit | 15.57 |
ENSMUST00000028467.5
|
proteoglycan 2, bone marrow |
|
chr6_-_40585783 Show fit | 15.11 |
ENSMUST00000177178.1
ENSMUST00000129948.2 ENSMUST00000101491.4 |
C-type lectin domain family 5, member a |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.1 | 48.2 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
11.5 | 34.6 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.5 | 32.2 | GO:0070527 | platelet aggregation(GO:0070527) |
1.2 | 29.1 | GO:0045730 | respiratory burst(GO:0045730) |
2.0 | 28.0 | GO:0033572 | transferrin transport(GO:0033572) |
1.4 | 27.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
2.4 | 24.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.1 | 23.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
1.7 | 22.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
6.7 | 20.2 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 45.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 40.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.6 | 38.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 32.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.4 | 28.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.9 | 26.3 | GO:0001891 | phagocytic cup(GO:0001891) |
2.3 | 25.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.5 | 25.0 | GO:0031430 | M band(GO:0031430) |
0.2 | 23.5 | GO:0005884 | actin filament(GO:0005884) |
0.3 | 19.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 48.1 | GO:0004601 | peroxidase activity(GO:0004601) |
5.1 | 40.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.7 | 38.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.8 | 30.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.8 | 28.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.9 | 28.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 28.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 26.0 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
3.1 | 25.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 24.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 66.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.1 | 51.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.8 | 50.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 46.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.8 | 36.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 34.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 30.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.6 | 28.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.8 | 24.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.5 | 23.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 46.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.8 | 44.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.7 | 35.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 31.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.7 | 27.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 26.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.8 | 26.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 25.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.3 | 25.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.7 | 24.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |